Kawin Technology(SH:688687)2026-02-27 08:25Revenue and Profit - Total revenue for 2025 reached RMB 132,078.27 million, representing a year-on-year increase of 7.35%[3] - Net profit attributable to shareholders of the parent company was RMB 2,963.12 million, a decrease of 79.19% compared to the previous year[3] - The company recorded a significant decline in operating profit, down 67.24% year-on-year, totaling RMB 6,323.57 million[3] - The net profit after deducting non-recurring gains and losses was RMB 2,276.47 million, down 83.38% year-on-year[3] - Basic earnings per share fell to RMB 0.17, down 80.00% from RMB 0.85 in the previous year[3] - The company attributed the significant decline in profits to a large asset impairment provision related to the withdrawal of a drug registration application[5] Assets and Equity - Total assets at the end of the reporting period amounted to RMB 279,463.78 million, reflecting a growth of 6.84% year-on-year[3] - The equity attributable to shareholders of the parent company decreased by 6.16% to RMB 172,975.34 million[3] Financial Metrics - The weighted average return on net assets decreased by 6.27 percentage points to 1.66%[3] - The company emphasizes that the financial data is preliminary and subject to final audit in the annual report[6]